Showing 141 - 150 of 51,541
This paper advances that WHO Member States, having agreed to the objectives of advancing equity and solidarity for future pandemic prevention, preparedness and response, now must operationalize these. The paper offers suggestions for the ongoing WHO processes of: 1) review of recommendations...
Persistent link: https://www.econbiz.de/10012886763
Drug shortages are emerging as a major public health threat. Grave concern has been expressed by the medical community and government officials, and the crisis has been highlighted in recent media stories. Nevertheless, little has been written to date in the legal literature about the drug...
Persistent link: https://www.econbiz.de/10014173190
We study the public goods problem associated with vaccinations. The externality created by an infection is composed of two parts, the probability of infection and the marginal infections generated if infected. We argue that the key component in a successful vaccination strategy is the second of...
Persistent link: https://www.econbiz.de/10014204430
pharmaceuticals. While political attention currently focuses on compulsory licensing under TRIPS, this article examines the article 27 … to exclude certain pharmaceuticals from patentability in order to enable affordable access for those affected by diseases …
Persistent link: https://www.econbiz.de/10014224715
This paper provides an analysis of patents covering selected antibodies and vaccines used in the treatment or prevention of COVID-19. The aim of the report is to support national patent offices and interested parties in developing countries with information that can serve as guidance for the...
Persistent link: https://www.econbiz.de/10014233696
The economic and health recovery of countries in the Asia-Pacific region from the pandemic is hinged on the rapid and equitable deployment of safe and effective COVID-19 vaccines. However, in the initial years of the COVID-19 vaccine roll-out, highly unequal distribution of vaccines occurred...
Persistent link: https://www.econbiz.de/10013449425
Physicians’ generic pharmaceutical adoption involves not only patients’ and insurance payers’ cost, but also their own interests. This study examines this double agency problem for physicians by using Taiwanese data because two of its institutional features: First, patients and physicians...
Persistent link: https://www.econbiz.de/10014129240
This thesis examines the legality issues of section 3(d) and section 84 of the Indian Patent Act, especially compliance with article 7, 8, 27, and 30 of the TRIPS Agreement. In addition, the potential conflicts and reconciliation between article 8 of the TRIPS Agreement and article 5(A)(2) of...
Persistent link: https://www.econbiz.de/10014120774
Penicillin and other antibiotics were the original wonder drugs and laid the foundation of the modern pharmaceutical industry. Human health significantly improved with the introduction of antibiotics. By 1967, the US Surgeon General declared victory over infectious diseases in the US. But pride...
Persistent link: https://www.econbiz.de/10014060278
WTO adopted the waiver solution in compulsory licensing, beginning from the Doha Declaration to the amendment of TRIPS Agreement, to facilitate access to medicine to the countries lacking manufacturing capacity. This article examines challenges faced by countries while issuing compulsory...
Persistent link: https://www.econbiz.de/10014040635